Allianz Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Allianz Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-232,872	Closed	-$2.61M	–	2823
2017 Q3	$2.61M	Sell	232,872 -34,020	-13%	-$375K	﹤0.01%	1901
2017 Q2	$2.93M	Buy	266,892 +147,947	+124%	+$1.48M	﹤0.01%	1849
2017 Q1	$1.17M	Buy	118,945 +15,144	+15%	+$151K	﹤0.01%	2191
2016 Q4	$1.12M	Buy	103,801 +21,149	+26%	+$211K	﹤0.01%	2179
2016 Q3	$834K	Buy	+82,652	New	+$900K	﹤0.01%	2257
2016 Q1	–	Sell	-13,963	Closed	-$128K	–	2655
2015 Q4	$128K	Sell	13,963 -1,770	-11%	-$14.8K	﹤0.01%	2418
2015 Q3	$109K	Sell	15,733 -31,607	-67%	-$271K	﹤0.01%	2291
2015 Q2	$465K	Buy	47,340 +21,393	+82%	+$195K	﹤0.01%	2159
2015 Q1	$230K	Hold	25,947	–	–	﹤0.01%	2167
2014 Q4	$227K	Sell	25,947 -585	-2%	-$4.74K	﹤0.01%	2171
2014 Q3	$183K	Buy	+26,532	New	+$159K	﹤0.01%	2171

Allianz Asset Management's SCLN Position: Q4 2017 in Review

Allianz Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 232,872 shares — an estimated $2.61M sold.

Allianz Asset Management first reported a position in SCLN in Q3 2014 and held it in 11 quarters. The position peaked at $2.93M in Q2 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Allianz Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Allianz Asset Management sold 232,872 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $2.61M.
Allianz Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and held it in 11 quarters.
Allianz Asset Management's Sciclone Pharmaceuticals Inc position peaked at $2.93M in Q2 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Allianz Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.